Tag Archive: asco

Progress in Prostate Cancer Research | Highlights on Lutetium-PSMA from the American Society of Clinical Oncology 2022 Annual Meeting

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest scientific meetings focused on cancer, where... Read More

U.S. Metastatic Prostate Cancer Diagnoses Increase After Reduction in PSA Screening

A reduction in prostate-specific antigen (PSA) screening in men aged 40 years and older was associated with an increase in... Read More

Addressing prostate cancer’s racial disparity starts with you

Several decades of data show that Black men are less likely to be screened and treated for prostate cancer than... Read More

FDA Approves Apalutamide for Metastatic Castration-Sensitive Prostate Cancer

The FDA has approved a supplemental New Drug Application (sNDA) for apalutamide (Erleada) for the treatment of patients with metastatic... Read More